Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
TAK-491
Known as:
TAK 491
, TAK491
National Institutes of Health
Create Alert
Related topics
Related topics
1 relation
Broader (1)
azilsartan medoxomil
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Development, validation and application of the liquid chromatography tandem mass spectrometry method for simultaneous quantification of azilsartan medoxomil (TAK-491), azilsartan (TAK-536), and its 2…
Yoji Kuze
,
A. Kogame
,
Fumihiro Jinno
,
T. Kondo
,
S. Asahi
Journal of chromatography. B, Analytical…
2015
Corpus ID: 25495644
Azilsartan medoxomil potassium salt (TAK-491) is an orally administered angiotensin II type 1 receptor blocker for the treatment…
Expand
2013
2013
Absorption of TAK-491, a new angiotensin II receptor antagonist, in animals
N. Kawaguchi
,
T. Ebihara
,
+6 authors
S. Asahi
Xenobiotica; the fate of foreign compounds in…
2013
Corpus ID: 19046066
The absorption process in animals of TAK-491, designed as ester-based prodrug with medoxomil moiety, was evaluated. In the plasma…
Expand
2011
2011
The Angiotensin Receptor Blocker, Azilsartan Medoxomil (TAK-491), Suppresses Vascular Wall Expression of Plasminogen Activator Inhibitor Type-I Protein Potentially Facilitating the Stabilization of…
Christopher J. French
,
A. T. Zaman
,
B. Sobel
Journal of cardiovascular pharmacology
2011
Corpus ID: 25176998
Increased expression of plasminogen activator inhibitor type-I (PAI-1) in vessel walls seems to accelerate atherosclerosis…
Expand
Review
2011
Review
2011
Azilsartan medoxomil: a new Angiotensin receptor blocker.
Kathy Zaiken
,
J. Cheng
Clinical therapeutics
2011
Corpus ID: 36449212
BACKGROUND Azilsartan medoxomil is an angiotensin receptor blocker, approved on February 25, 2011 by the US Food and Drug…
Expand
Review
2011
Review
2011
Azilsartan Medoxomil: A New Angiotensin II Receptor Antagonist for Treatment of Hypertension
W. Baker
,
W. White
The Annals of pharmacotherapy
2011
Corpus ID: 207264457
Objective: To evaluate the efficacy, safety, and clinical role of azilsartan medoxomil, an angiotensin II receptor blocker (ARB…
Expand
2011
2011
INHIBITION OF THE ANGIOTENSIN II TYPE-1 (AT-1) RECEPTOR BY THE ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL (TAK-491) SUPPRESSES AORTIC EXPRESSION OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-I (PAI…
Christopher J. French
,
P. Q. Baumann
,
D. Neimane
,
Keara McElroy-Yaggy
,
T. Zaman
,
B. Sobel
2011
Corpus ID: 71643550
2010
2010
Additive Effect of TAK-491, a New Angiotensin Receptor Blocker, and Pioglitazone, in Reducing Myocardial Infarct Size
Y. Ye
,
K. Keyes
,
C. Zhang
,
J. Perez-polo
,
Yu Lin
,
Y. Birnbaum
Cardiovascular Drugs and Therapy
2010
Corpus ID: 26277932
PurposeWe assessed the effects of TAK-491 (a newly designed potent and selective ARB) alone and in combination with pioglitazone…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE